0 items

in your cart
$0.00

Prescription Drug Search

Strengths available for Pirfenidone :

Pirfenidone 200mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Pirfenidone:

  • Argentina
  • Armenia
  • Austria
  • Bangladesh
  • Barbados
  • Bolivia
  • Bulgaria
  • Cayman Islands
  • Colombia
  • Cuba
  • Cyprus
  • El Salvador
  • Fiji
  • Finland
  • Georgia
  • Gibraltar
  • Grenada
  • Hungary
  • India
  • Jordan
  • Korea, South
  • Lebanon
  • Morocco
  • New Zealand
  • Panama
  • Paraguay
  • Qatar
  • Saint Lucia
  • Saudi Arabia
  • Serbia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • Taiwan
  • Thailand
  • Trinidad and Tobago
  • Turkey
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Pirfenidone:

InterMune to Divest Actimmune® (Interferon Gamma-1b) - Yahoo Finance

The divesture of Actimmune will provide additional capital for InterMune to continue to focus on and invest in the registration and commercialization of Esbriet® (pirfenidone) in Europe and elsewhere and to continue to advance our R&D programs.

Canaccord Genuity Reiterates a 'Buy' on InterMune Inc. (ITMN); Reducing Estimates and PT - StreetInsider.com

Analyst, Ritu Baral, said, "Reiterate rating, lowering target to $15 on lower, but still blockbuster, Esbriet (pirfenidone) sales prospects. Esbriet is ITMN’s drug for idiopathic pulmonary fibrosis (IPF), an orphan lung disease. We see good Esbriet EU ...

InterMune deal delivers $55M in fresh fuel for fibrosis drug - FierceBiotech

The money is being used to fuel the launch of pirfenidone (Esbriet) in Europe, a new treatment for idiopathic pulmonary fibrosis. The FDA, though, rejected the drug in 2010, forcing InterMune to mount a new late-stage study as the company ...

Govt sets up panel to check on drugs regulator - Livemint.com

The report also said that P. Prabhudesai, chest specialist at Lilavati Hospital in Mumbai, was one of the four doctors who approved Cipla Ltd’s drug pirfenidone, used to treat lung disorder, in 2010. Prabudesai denied ever having been in touch ...

Medical body demands ban on 33 drugs in India - deccanchronicle.com

Everolimus (Novartis), Colistimethate (Cipla), Exemestane (Pharmacia), Buclizine (UCB), Pemetrexid (Eli Lilly), Aliskiren (Novartis), Pentosan (West Coast), Ambrisentan (GlaxoSmithKline), Ademetionine (Akums), Pirfenidone (Cipla), and FDC of Pregabalin ...

Probe finds collusion between India's drug regulator, pharma firms - msnbc.com

Bayer said it had no immediate comment. The report said in another instance, letters from medical experts recommended approval of the drug Pirfenidone, marketed by Indian pharmaceutical company Cipla, which has the second-largest share of the ...

Rare and Niche Diseases Catalyst Monitor - Key Event Analysis H1 2012 - SBWire

Intermune’s Esbriet (pirfenidone), for idiopathic pulmonary fibrosis (IPF): additional launches in France, Spain, and Italy in H1. Reasons to Buy - Understand the key therapeutic areas that are driving the rare and niche disease markets, which will ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK